CONMED Corporation (FRA:EC8)

Market Cap	1.32B +1.3%
Revenue (ttm)	1.20B +3.4%
Net Income	49.45M -48.7%
EPS	1.64 -48.0%
Shares Out	n/a
PE Ratio	26.53
Forward PE	11.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52
Open	43.60
Previous Close	43.80
Day's Range	43.20 - 43.60
52-Week Range	27.60 - 45.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About CONMED

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1970
• Employees: 3,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EC8

Financial Performance

In 2025, CONMED's revenue was $1.37 billion, an increase of 5.18% compared to the previous year's $1.31 billion. Earnings were $47.06 million, a decrease of -64.47%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error